My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by AliveGen USA Inc.
AliveGen Presents Preclinical Data Showing ALG-801 Outperforms Standard Therapies in Pulmonary Arterial Hypertension Model
October 01, 2025
From
AliveGen USA Inc.
Via
Business Wire
AliveGen Receives FDA Orphan Drug Designation for ALG-801 for Pulmonary Arterial Hypertension
January 07, 2025
From
AliveGen USA Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.